Willi Miesch has been CEO of medical technology company Medartis AG since its founding in 1998. Medartis specializes in high-precision implants for surgical fixation of bone fractures and osteotomies.
Willi’s career started with an apprenticeship as a precision engineer. He later extended his qualifications through degree and postgraduate studies in engineering and market-oriented business management. He also gained extensive experience and insight in the medtech industry working at Institut Straumann AG Switzerland and Stratec Medical.
As CEO, Willi has grown Medartis into a US$100m company with almost 400 employees worldwide. As a member of the Investment Advisory Committee of MTIP, Willi uses his entrepreneurial experience in the assessment and selection of medtech start-ups.